Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)

Summary of Organon & Co. Conference Call Company Overview - Company: Organon & Co. (NYSE: OGN) [1] - Event: 42nd Annual Cowen Health Care Conference [1] Key Points Discussed Industry Focus - The conference primarily centered on the women's health sector, highlighting its significance in Organon's product portfolio [4] Product Performance - NEXPLANON: - Achieved the highest sales in Q4, marking a record quarter for the product [4] - Management expressed confidence in maintaining this sales level, indicating a new growth trajectory for NEXPLANON [5] Management Insights - Kevin Ali (CEO) emphasized the importance of understanding the background of sales growth, suggesting that it was a result of a strategic building process [5] Additional Important Information - The management team included key figures such as the CEO, CFO, Head of R&D, and Head of Investor Relations, indicating a strong leadership presence during the conference [2][3]